VANGUARD GROUP INC - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 31 filers reported holding VIVOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$118,144
-67.6%
615,015
-13.9%
0.00%
Q2 2023$364,194
+48.5%
714,106
-0.7%
0.00%
Q1 2023$245,308
-16.6%
719,167
-1.7%
0.00%
Q4 2022$294,200
-38.1%
731,842
+0.1%
0.00%
Q3 2022$475,000
-47.0%
731,378
+5.2%
0.00%
Q2 2022$897,000
-51.8%
695,0510.0%0.00%
Q1 2022$1,862,000
+24.8%
695,051
+4.8%
0.00%
Q4 2021$1,492,000
-40.2%
663,253
+7.5%
0.00%
Q3 2021$2,494,000
+31.3%
617,251
+60.8%
0.00%
Q2 2021$1,900,000383,8910.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Strategic Wealth Investment Group, LLC 3,219,705$1,098,2410.20%
BARD ASSOCIATES INC 201,704$68,8020.03%
PERKINS CAPITAL MANAGEMENT INC 22,500$80.01%
GODSEY & GIBB, INC 92,999$31,7220.00%
Virtu Financial LLC 46,013$160.00%
Wealth Alliance Advisory Group, LLC 17,498$5,9690.00%
Apexium Financial, LP 40,667$13,8720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,308$4460.00%
GEODE CAPITAL MANAGEMENT, LLC 201,941$68,8820.00%
View complete list of VIVOS THERAPEUTICS INC shareholders